# APELLIS PHARMACEUTICALS INC (APLS)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/APLS/

- Reporting holders: 3
- Reported value: $1.8M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Louisiana State Employees Retirement System](https://holderbook.com/funds/1537191-louisiana-state-employees-retirement-system/) | $1.8M | 45,400 | 0.0% | 2 |
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $10.2K | 248 | 0.0% | 15 |
| [MV CAPITAL MANAGEMENT, INC.](https://holderbook.com/funds/1633366-mv-capital-management-inc/) | $242 | 6 | 0.0% | 9 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 3 | $1.8M |
| Q1 2026 | 326 | $5.7B |
| Q4 2025 | 284 | $3.3B |
| Q3 2025 | 281 | $2.9B |
| Q2 2025 | 251 | $2.4B |
| Q1 2025 | 257 | $2.9B |
| Q4 2024 | 268 | $4.2B |
| Q3 2024 | 274 | $3.7B |
| Q2 2024 | 266 | $4.9B |
| Q1 2024 | 307 | $7.2B |
| Q4 2023 | 292 | $7.7B |
| Q3 2023 | 269 | $4.9B |